- Home
- RVPH vs KLXE Comparison
RVPH vs KLXE Comparison
Compare RVPH & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- KLXE
- Stock Information
- Founded
- RVPH 2006
- KLXE 2018
- Country
- RVPH United States
- KLXE United States
- Employees
- RVPH N/A
- KLXE N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- KLXE Oilfield Services/Equipment
- Sector
- RVPH Health Care
- KLXE Energy
- Exchange
- RVPH Nasdaq
- KLXE Nasdaq
- Market Cap
- RVPH 30.1M
- KLXE 35.8M
- IPO Year
- RVPH N/A
- KLXE N/A
- Fundamental
- Price
- RVPH $0.40
- KLXE $1.81
- Analyst Decision
- RVPH Strong Buy
- KLXE
- Analyst Count
- RVPH 5
- KLXE 0
- Target Price
- RVPH $5.20
- KLXE N/A
- AVG Volume (30 Days)
- RVPH 1.3M
- KLXE 86.8K
- Earning Date
- RVPH 11-13-2025
- KLXE 10-30-2025
- Dividend Yield
- RVPH N/A
- KLXE N/A
- EPS Growth
- RVPH N/A
- KLXE N/A
- EPS
- RVPH N/A
- KLXE N/A
- Revenue
- RVPH N/A
- KLXE $667,400,000.00
- Revenue This Year
- RVPH N/A
- KLXE N/A
- Revenue Next Year
- RVPH N/A
- KLXE $3.97
- P/E Ratio
- RVPH N/A
- KLXE N/A
- Revenue Growth
- RVPH N/A
- KLXE N/A
- 52 Week Low
- RVPH $0.30
- KLXE $1.46
- 52 Week High
- RVPH $4.28
- KLXE $7.40
- Technical
- Relative Strength Index (RSI)
- RVPH 34.75
- KLXE 46.55
- Support Level
- RVPH $0.50
- KLXE $1.73
- Resistance Level
- RVPH $0.47
- KLXE $1.94
- Average True Range (ATR)
- RVPH 0.03
- KLXE 0.12
- MACD
- RVPH -0.01
- KLXE -0.01
- Stochastic Oscillator
- RVPH 14.30
- KLXE 19.05
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About KLXE KLX Energy Services Holdings Inc.
KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.